Our pandemic response enhanced in-house capabilities in virology testing and beyond

MLO Online Article: “Our pandemic response enhanced in-house capabilities in virology testing and beyond”

Introduction:
“Reflecting on the start of the COVID-19 pandemic, the memories are painful—the desperate need for clinical testing when none was available; quickly developing novel molecular COVID tests with the majority being imperfect; establishing and maintaining safe practices for handling COVID samples in the lab. Through teamwork and innovation, we persevered, eventually ramping up to perform 2,000 tests per day and, after three years, over 900,000 COVID molecular assays in total.”

Authors:
Sonia Benhamed, PharmD, SMB(ASCP)
Michael Mihalov, MD

Available online from August 24, 2023, or click below to download PDF

 

Download